Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$57.77 - $65.93 $4,390 - $5,010
76 New
76 $4,000
Q1 2020

May 06, 2020

SELL
$63.18 - $85.97 $2,337 - $3,180
-37 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$73.04 - $95.72 $2,702 - $3,541
37 New
37 $3,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.